Lb Pharmaceuticals (LBRX) Accumulated Expenses (2024 - 2026)

Lb Pharmaceuticals' Accumulated Expenses history runs 3 years deep, the most recent figure standing at $262000.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses changed N/A year-over-year to $262000.0; the TTM figure through Mar 2026 stood at $262000.0 (changed N/A YoY), while the FY2025 annual figure was $515000.0, down 35.62% from the prior year.
• Accumulated Expenses was $262000.0 for Q1 2026 at Lb Pharmaceuticals, down from $515000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.1 million in Q3 2025 to a low of $262000.0 in Q1 2026.
• Historically, Accumulated Expenses has averaged $675750.0 across 3 years, with a median of $657500.0 in 2024.
• Biggest YoY gain for Accumulated Expenses was 35.62% in 2025; the steepest drop was 35.62% in 2025.
• A 3-year view of Accumulated Expenses shows it stood at $800000.0 in 2024, then sank by 35.62% to $515000.0 in 2025, then slumped by 49.13% to $262000.0 in 2026.
• The last three Accumulated Expenses figures came in at $262000.0 (Q1 2026), $515000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.